We occasionally hear some version of this from startup founders:
“We’re losing money anyway. I don’t want to deal with the R&D credit.”
That is not necessarily a bad decision.
The federal R&D tax credit can require additional analysis, documentation and cost. Sometimes the expected benefit is small. Sometimes engineering time was never tracked in a useful way. Sometimes much of the development happened outside the United States and will not qualify. And sometimes the founders simply do not want another tax project competing for their attention.
But there is an important difference between deciding the credit is not worth pursuing and assuming there is no downside to waiting.
For some early-stage companies, waiting can mean giving up options that cannot simply be recreated later.
01Sometimes Passing Really Does Make Sense
Not every company with engineers qualifies for the R&D credit, and not every company that qualifies should necessarily spend money pursuing it.
The credit has specific requirements. Broadly, the work must involve technological uncertainty and a process of experimentation aimed at developing or improving a product, process, software or other business component. Certain activities are excluded. Research performed outside the United States generally does not qualify.
The economics matter too.
A company with a small amount of qualifying activity may find that the expected benefit does not justify the cost and administrative burden. A startup with poor historical records may face a much heavier documentation exercise than one that has maintained useful payroll, contractor and development records from the beginning.
Passing can be a business decision.
But “we do not owe income tax” is a different argument.
02A Startup With Tax Losses May Still Be Able to Use the Credit
Early-stage startups often assume tax credits only matter once they become profitable.
For certain qualified small businesses, that is not the case.
Eligible companies can elect to apply up to $500,000 of their research credit against payroll taxes rather than waiting until they have federal income tax liability.
For a startup already paying engineers and other employees, that can turn a tax attribute into a more immediate cash benefit.
This is also where timing starts to matter.
The payroll tax election generally has to be made on the company’s original income tax return by its due date, including extensions.
That means a founder may be able to revisit the underlying R&D credit later, but the opportunity to use that year’s credit against payroll taxes may already be gone.
Those are two very different outcomes.
03“We’ll Claim It Later” May Not Preserve the Same Choices
There is a common assumption that tax credits are easy to revisit.
If the company is not paying income tax today, why not wait a few years, calculate the credit once the company is profitable, and amend the old returns?
Sometimes a research credit can in fact be claimed later. Unused general business credits can also generally be carried forward for up to 20 years.
But that does not mean waiting leaves the company in exactly the same position.
The payroll tax election has its own deadline. The Section 280C reduced-credit election also generally must be made on a timely filed original return and cannot simply be added later on an amended return.
So the better question is not:
“Can we still claim an R&D credit later?”
It is:
“What choices are we giving up if we do not address it now?”
For a startup, that distinction can matter considerably.
04The Section 174 Rules Changed Again
There is another reason some founders may be working from outdated assumptions.
For tax years beginning in 2022 through 2024, companies generally had to capitalize and amortize domestic research and experimental expenditures over five years. That rule created significant tax consequences for startups with large engineering teams, even when they were spending cash and reporting book losses.
Beginning with tax years after 2024, new Section 174A generally allows current deductions for domestic research and experimental expenditures again.
Foreign research is different and generally remains subject to 15-year amortization.
The R&D credit still interacts with the deduction rules, including through Section 280C, so claiming a credit is not completely separate from the company’s R&D expense treatment.
But the analysis in 2025 and later is not the same analysis startups were dealing with during the 2022 through 2024 capitalization years.
That is another reason relying on an old conclusion about whether the credit was “worth it” can be misleading.
05What Happens If the Company Is Acquired?
An R&D credit does not automatically make a startup more valuable.
A buyer is not necessarily going to increase its purchase price dollar for dollar because the target has unused tax credits.
But historical tax attributes can matter in a transaction.
Unused research credits and the records supporting them may become part of tax diligence. Depending on the transaction and ownership changes, there can also be limits on how quickly pre-acquisition credits may be used.
The more practical issue is often documentation.
It is much easier to understand what an engineering team was building, who worked on it and how the development process operated while those people are still at the company and the records are current.
Trying to reconstruct several years of R&D activity shortly before a financing or acquisition is a very different exercise.
So the value is not simply “we have an R&D credit.”
It is also having a tax history that can be explained and supported when someone eventually asks about it.
06The Decision Is Not Always “Claim It” or “Don’t Claim It”
For some companies, pursuing the R&D credit will not make economic sense.
For others, particularly wage-heavy early-stage companies that may qualify for the payroll tax offset, passing could mean leaving a meaningful cash benefit unused.
The important part is understanding the tradeoff before the filing deadline passes.
Because there is a big difference between intentionally deciding that a credit is not worth pursuing and finding out later that an option disappeared while you were waiting.
Not Sure Whether the R&D Credit Is Worth Pursuing?
Talara can help estimate the potential benefit and identify the facts that matter before you invest in a full R&D study.
The goal is not to claim every possible tax credit. It is to know what you are giving up before you decide to pass.
This article is general information, not tax or legal advice. The rules are fact-specific, change over time, and depend on details unique to your company. Talk to us about how they apply to your situation.